GlaxoSmithKline PLC Director/PDMR Shareholding (6524P)
11 Febrero 2019 - 6:01AM
UK Regulatory
TIDMGSK
RNS Number : 6524P
GlaxoSmithKline PLC
11 February 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
======================================================================
a) Name Mr R G Connor
=== ======================== ============================================
b) Position/status President, Global Vaccines
=== ======================== ============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ======================== ============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ============================================
b) Nature of the The exercise of options over 6,910 Ordinary
transaction Shares, granted on 17 February 2009 under
the GlaxoSmithKline Share Option Plan.
=== ======================== ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) GBP11.7700 6,910
----------
=== ======================== ============================================
d) Aggregated information
Aggregated volume n/a (single transaction)
Price
=== ======================== ============================================
e) Date of the transaction 2018-02-08
=== ======================== ============================================
f) Place of the n/a
transaction
=== ======================== ============================================
1. Details of PDMR/person closely associated with them
('PCA')
========================================================================
a) Name Mr R G Connor
=== ======================== ==============================================
b) Position/status President, Global Vaccines
=== ======================== ==============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ==============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ==============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ==============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ==============================================
b) Nature of the The sale of 6,910 Ordinary Shares, granted
transaction on 17 February 2009 under the GlaxoSmithKline
Share Option Plan.
=== ======================== ==============================================
c) Price(s) and Price(s) Volume(s)
volume(s) GBP15.5781 6,910
----------
=== ======================== ==============================================
d) Aggregated information
Aggregated volume n/a (single transaction)
Price
=== ======================== ==============================================
e) Date of the transaction 2019-02-08
=== ======================== ==============================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ==============================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHFFLFFKLFEBBD
(END) Dow Jones Newswires
February 11, 2019 07:01 ET (12:01 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024